Strax (STRAX) Q3 2024 earnings summary

Executive summary

• Net sales for Jan–Sep 2024 were MEUR 7.4, down from MEUR 25.0 year-over-year, with a gross margin of -65.0% (4.3%).

• Result for the period was MEUR -1.9 (-25.5), or EUR -0.02 (-0.24) per share.

• EBITDA from continuing operations for Jan–Sep 2024 was MEUR -1.5 (-22.0).

• Sales in Q3 2024 were MEUR 0.9 (8.3), an 89% decline compared to Q3 2023, with sales now concentrated in the Americas.

• Significant progress made in reducing operating expenses and pursuing debt reduction and liquidity improvement strategies.

Financial highlights

• Gross profit for Jan–Sep 2024 was MEUR -4.8 (1.1), with a negative gross margin of -65.0% (4.3%).

• Operating profit for Jan–Sep 2024 was MEUR -1.7 (-23.0).

• Cash and cash equivalents as of Sep 30, 2024, were MEUR 0.08 (0.91).

• Equity as of Sep 30, 2024, was MEUR -73.6 (-33.6), with an equity/assets ratio of -1,819.5% (-58.2%).

• Interest-bearing liabilities as of Sep 30, 2024, were MEUR 5.8 (37.6).

Outlook and guidance

• Focus remains on stabilizing and saving the company, with a recovery plan centered on Urbanista and Matter Brands and diversification into health tech.

• Restructuring initiatives are ongoing, with future focus on mobile accessories and personal audio.

• Next steps and future strategy to be communicated in December 2024.